- Home
- VTR vs BNTX Comparison
VTR vs BNTX Comparison
Compare VTR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTR
- BNTX
- Stock Information
- Founded
- VTR 1983
- BNTX 2008
- Country
- VTR United States
- BNTX Germany
- Employees
- VTR N/A
- BNTX N/A
- Industry
- VTR Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VTR Real Estate
- BNTX Health Care
- Exchange
- VTR Nasdaq
- BNTX Nasdaq
- Market Cap
- VTR 27.3B
- BNTX 23.9B
- IPO Year
- VTR 1998
- BNTX 2019
- Fundamental
- Price
- VTR $59.90
- BNTX $120.38
- Analyst Decision
- VTR Buy
- BNTX Strong Buy
- Analyst Count
- VTR 10
- BNTX 15
- Target Price
- VTR $61.60
- BNTX $143.50
- AVG Volume (30 Days)
- VTR 2.4M
- BNTX 972.4K
- Earning Date
- VTR 02-12-2025
- BNTX 11-04-2024
- Dividend Yield
- VTR 3.00%
- BNTX N/A
- EPS Growth
- VTR N/A
- BNTX N/A
- EPS
- VTR N/A
- BNTX N/A
- Revenue
- VTR $4,797,115,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- VTR N/A
- BNTX N/A
- Revenue Next Year
- VTR $7.07
- BNTX N/A
- P/E Ratio
- VTR N/A
- BNTX N/A
- Revenue Growth
- VTR 10.05
- BNTX N/A
- 52 Week Low
- VTR $41.45
- BNTX $76.53
- 52 Week High
- VTR $67.61
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- VTR 29.44
- BNTX 57.39
- Support Level
- VTR $61.73
- BNTX $116.73
- Resistance Level
- VTR $62.29
- BNTX $123.30
- Average True Range (ATR)
- VTR 1.06
- BNTX 4.49
- MACD
- VTR -0.34
- BNTX 0.45
- Stochastic Oscillator
- VTR 4.98
- BNTX 59.65
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.